Cellulite Treatment Market is estimated to surge at a CAGR of 7.8% through 2028

 Future Market Insights (FMI) has released a new research report that examines the present state of the worldwide cellulite treatment market as well as forecasts for the coming years. Cellulite Treatment Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028 is the title of this thorough research report.

The global Cellulite Treatment Market is expected to be worth US$ 3.3 billion in 2022, and it is expected to grow at a 7.8% CAGR to reach US$ 5.2 billion by 2028.

Cellulite is a health condition that is more prevalent in women. With the growing health-related complexities witnessed in women, there’s also a growth in the rate of people suffering from cellulite.

Hard Cellulite Predicted to Hold an Attractive Market Share in the Near Future

One major driver behind the growth of the cellulite treatment market is the increasing number of obese population. There are also an increased number of cases for fat deposition. People who are comparatively overweight mostly face this problem, in turn triggering the demand for cellulite treatment. These cases have helped people grow aware about cosmetic surgeries and has also broadened the scope of these surgeries in market. There’s a significant rise in aesthetic procedures taking place worldwide.

Especially in Brazil, where there were around 5,500 cosmetic surgeons performing the second highest number of aesthetic procedures after the U.S. Around 1,450,020 minimally invasive and non-surgical procedures were performed in Brazil in 2016. Among different types of cellulite, hard cellulite is expected to register a growth rate of around 7.8% during 2022-2028, which is higher than other cellulite types.

To learn more about this report: https://www.futuremarketinsights.com/reports/cellulite-treatment-market

Key Companies Profiled:

·         Merz Pharma GmbH & Co. KGaA

·         Cynosure Inc. (Sub. Hologic Inc.)

·         Tanceuticals LLC

·         Inceler Medikal Co. Ltd.

·         Cymedics

·         Nubway

·         Zimmer Aesthetics

·         Syneron Medical Inc.

North America Slated for Strongest Projections in the Global Cellulite Treatment Market

Among the major regional divisions made for the research conducted on the global cellulite treatment market, North America shows the strongest prospects with an expected market value of over US$ 2,100 Mn by the end of 2028, growing at an impressive CAGR of 8.1% during the forecast period. The growth is helped by North America’s moderate economy and healthcare market.

Also, in the U.S., a large base of the population, especially youngsters, suffer from fat deposition-related disorders. The region is also ahead of other regions due to its developed economy and advanced facilities. The cellulite treatment involves advanced techniques which are also costly for people to afford. This makes the market more prominent in developed regions like North America.

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more